Rubisco Biotechnology Spa
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Rubisco Biotechnology Spa - overview
Established
2015
Location
Santiago, -, Chile
Primary Industry
Biotechnology
About
Founded in 2015 and based in Santiago, Chile, Rubisco Biotechnology Spa is a biotechnology company that specializes in the research, development, and production of natural active ingredients derived from native species. The company was co-founded by Jose Pablo Garcia (CEO) and others. In April 2023, Rubisco Biotechnology raised USD 0. 75 million in venture funding from Sudlich Capital.
The company’s flagship product is AustralCell™ Alerce, which repairs the skin and combats premature ageing caused by environmental pollution and blue light exposure. The firm’s product has a unique and natural formulation that demonstrates efficacy in countering the effects of ageing and protecting the skin. RubiscoLab also provides Rubisco services, including preclinical testing of dermocosmetic ingredients for safety and efficacy. The company’s services encompass phytochemical characterization, safety studies of plant extracts, and evaluations of the cosmetic efficacy of these extracts.
Rubisco provides an R&D platform that allows users to capitalise on the key advantages of its vegetable crops. The organization plans to use the April 2023 funding to accelerate growth and expansion.
Current Investors
Sudlich Capital
Primary Industry
Biotechnology
Sub Industries
Biotechnology
Website
www.rubiscolab.com
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Rubisco Biotechnology Spa - employee data


Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.